Author: <span>Mesothelioma News</span>

Targovax submits a study of its adenovirus based immune therapy…

Targovax has submitted a study protocol to the regulatory authorities in Spain to assess its ONCOS-102 product in combination with chemotherapy in patients with malignant pleural mesothelioma , a rare type of lung cancer associated with exposure to asb…

Spotlight on both old, difficult issues and humanitarian visions that drive new patents

The current issue of Technology and Innovation, Journal of the National Academy of Inventors focuses on old but important issues in health-related environmental research, illuminates new trends, including rewarding patents born of humanitarian vision, …

State, building supply makers ordered to pay redress for asbestos contamination

A court ordered the state and nine makers of building materials on Friday to pay 216 million in damages to former construction workers and their families for illnesses they developed after being exposed to asbestos at construction sites. A total of 27 …

Asbestos a potential cancer threat, even 40 to 50 years after exposure

Recent Stats Canada figures show a rise in the numbers of cases and deaths from mesothelioma, a deadly cancer caused primarily by workplace asbestos exposure. You could be forgiven for thinking asbestos is part of our past, but new statistics show case…